Quick Answer
Teladoc Health, Inc. reported Revenue (ASC 606) of $2.53 billion for fiscal year 2025.
Teladoc Health, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $2.53B | -1.5% |
| 2024 | $2.57B | -1.3% |
| 2023 | $2.60B | +8.1% |
| 2022 | $2.41B | +18.4% |
| 2021 | $2.03B | +85.8% |
| 2020 | $1.09B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $626.44M | -2.2% | -0.9% |
| June 30, 2025 | $631.90M | -1.6% | +0.4% |
| March 31, 2025 | $629.37M | -2.6% | -1.7% |
| September 30, 2024 | $640.51M | -3.0% | -0.3% |
| June 30, 2024 | $642.44M | -1.5% | -0.6% |
| March 31, 2024 | $646.13M | +2.7% | -2.1% |
| September 30, 2023 | $660.24M | +8.0% | +1.2% |
| June 30, 2023 | $652.41M | +10.1% | +3.7% |
- Teladoc Health, Inc. showed a decrease of -1.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, Teladoc Health, Inc.’s revenue (asc 606) has grown by 131.3% (from $1.09 billion to $2.53 billion).
- The most recent figure is from Teladoc Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: